INS and metabolic syndrome: IR is a critical component of metabolic syndrome, obesity, and hyperlipidemia and is a risk factor for cardiovascular diseases (CVDs) and type 2 diabetes (T2D), especially when an insulin-resistant individual cannot secrete enough insulin from pancreatic β-cells [1,2].